SINT vs. MOTS, BJDX, INVO, ALLR, NVTA, ACORQ, BTTX, ADTX, BLPH, and SIENQ
Should you be buying Sintx Technologies stock or one of its competitors? The main competitors of Sintx Technologies include Motus GI (MOTS), Bluejay Diagnostics (BJDX), INVO Bioscience (INVO), Allarity Therapeutics (ALLR), Invitae (NVTA), Acorda Therapeutics (ACORQ), Better Therapeutics (BTTX), Aditxt (ADTX), Bellerophon Therapeutics (BLPH), and Sientra (SIENQ). These companies are all part of the "medical" sector.
Sintx Technologies (NASDAQ:SINT) and Motus GI (NASDAQ:MOTS) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their community ranking, earnings, profitability, institutional ownership, valuation, media sentiment, dividends, analyst recommendations and risk.
Motus GI received 127 more outperform votes than Sintx Technologies when rated by MarketBeat users. Likewise, 65.73% of users gave Motus GI an outperform vote while only 61.02% of users gave Sintx Technologies an outperform vote.
18.4% of Sintx Technologies shares are held by institutional investors. Comparatively, 20.1% of Motus GI shares are held by institutional investors. 0.8% of Sintx Technologies shares are held by company insiders. Comparatively, 1.6% of Motus GI shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Sintx Technologies has higher revenue and earnings than Motus GI. Sintx Technologies is trading at a lower price-to-earnings ratio than Motus GI, indicating that it is currently the more affordable of the two stocks.
Sintx Technologies has a net margin of -314.39% compared to Motus GI's net margin of -4,033.54%. Motus GI's return on equity of 0.00% beat Sintx Technologies' return on equity.
Sintx Technologies has a beta of 1.46, suggesting that its stock price is 46% more volatile than the S&P 500. Comparatively, Motus GI has a beta of 1.3, suggesting that its stock price is 30% more volatile than the S&P 500.
Motus GI has a consensus target price of $28.88, suggesting a potential upside of 29,978.13%. Given Motus GI's stronger consensus rating and higher probable upside, analysts plainly believe Motus GI is more favorable than Sintx Technologies.
In the previous week, Sintx Technologies' average media sentiment score of 0.00 equaled Motus GI'saverage media sentiment score.
Summary
Motus GI beats Sintx Technologies on 10 of the 16 factors compared between the two stocks.
Get Sintx Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for SINT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SINT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Sintx Technologies Competitors List
Related Companies and Tools
